
Lung Disease in Systemic Sclerosis
ACR on Air
00:00
Innovative Clinical Trials for Systemic Sclerosis and Lung Disease
Exploring the innovative platform clinical trial method in the conqurest study sponsored by the Scleroderma Research Foundation, aiming to improve treatments for systemic sclerosis and lung disease. Emphasizing the importance of efficiency and collaboration in testing multiple medications simultaneously for Scleroderma patients.
Transcript
Play full episode